Home » Chinese Healthcare Investors »


|| Chinese investors of Citic acquired stake at Singapore medical firm for $817 million

citic-singaporeCitic Private Equity, a Chinese private equity firm, has acquired stake at Biosensors International Group, a Singapore-based medical device maker, for $817 million.

Citic Private Equity Funds Management already controls about 19.6 percent of Biosensors. Biosensors International Group is a medical device company that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The company was listed in the Mainboard of the Singapore Exchange (SGX) in May 2005. (CITIC Capital Partners, the private equity arm of CITIC Capital, invests globally, operates in China, Japan and the US and manages $2.6 billion of committed capital.)

Citic Private Equity is listed in the Chinese Private Equity and Venture Capital Directory with the code OR48

More details follows from Bloomberg



Previous Post: Chinese firm Anbang acquired US Insurance firm FGL for $1.57 billion
Next Post: Chinese investors of CBanner to acquire UK historic toy store Hamleys for $153 million




| About Us

Rubenstein
SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.



|Subscribe to mailing list

Enter your email address:



Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2018     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on Google+  |   SinaBeat on LinkedIn